INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Outset Medical, Inc. - OM

NEW YORK , Dec. 11, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Outset Medical, Inc. ("Outset Medical" or the "Company") (NASDAQ: OM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

PRNewsWire • Dec 11, 2025

INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Outset Medical, Inc. (NASDAQ: OM) and Encourages Investors with Substantial Losses to Contact the Firm

NEWTOWN, Pa. , Nov. 28, 2025 /PRNewswire/ -- Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Outset Medical, Inc. (NASDAQ: OM), resulting from allegations of providing potentially misleading business information to the investing public.

PRNewsWire • Nov 28, 2025

Outset Medical, Gemini Space Station, CoreWeave And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

U.S. stock futures were mostly lower this morning, with the S&P 500 futures falling around 0.2% on Tuesday.

Benzinga • Nov 11, 2025

Outset Medical, Inc. (OM) Q3 2025 Earnings Call Transcript

Outset Medical, Inc. ( OM ) Q3 2025 Earnings Call November 10, 2025 4:30 PM EST Company Participants James Mazzola - Vice President of Corporate Communications & Investor Relations Leslie Trigg - President, CEO & Chairman Renee Gaeta - CFO, Principal Financial Officer & Principal Accounting Officer Conference Call Participants Frederick Wise - Stifel, Nicolaus & Company, Incorporated, Research Division Shagun Singh Chadha - RBC Capital Markets, Research Division Marie Thibault - BTIG, LLC, Research Division Joshua Jennings - TD Cowen, Research Division Presentation Operator Good day, and thank you for standing by. Welcome to the Outset Medical Q3 2025 Earnings Conference Call.

Seeking Alpha • Nov 11, 2025

Outset Medical Reports Third-Quarter Results

SAN JOSE, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today reported financial results for the third quarter ended September 30, 2025 and revised its 2025 revenue guidance.

GlobeNewsWire • Nov 10, 2025

Outset Medical, Inc. (OM) Reports Q3 Loss, Lags Revenue Estimates

Outset Medical, Inc. (OM) came out with a quarterly loss of $0.69 per share versus the Zacks Consensus Estimate of a loss of $0.64. This compares to a loss of $5.85 per share a year ago.

Zacks Investment Research • Nov 11, 2025

New Research Demonstrates the Advantages of an Insourced Dialysis Service Line for Acute-Care Facilities Using Outset Medical's Tablo® Hemodialysis System

Data from over 1 Million Tablo Treatments Among the Findings Presented at the American Society of Nephrology's Kidney Week 2025 Data from over 1 Million Tablo Treatments Among the Findings Presented at the American Society of Nephrology's Kidney Week 2025

GlobeNewsWire • Nov 5, 2025

Outset Medical to Present at the 2025 Stifel Healthcare Conference

SAN JOSE, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will present at the 2025 Stifel Healthcare conference on Wednesday, November 12, 2025, at 10:40 a.m.

GlobeNewsWire • Nov 5, 2025

Outset Medical to Report Third Quarter 2025 Financial Results on Monday, November 10, 2025

SAN JOSE, Calif., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the third quarter 2025 after the close of trading on Monday, November 10, 2025.

GlobeNewsWire • Oct 27, 2025

Outset Medical, Inc. (OM) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Outset Medical, Inc. (NASDAQ:OM ) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 7:00 AM EDT Company Participants Leslie Trigg - President, CEO & Chairman Renee Gaeta - CFO, Principal Financial Officer & Principal Accounting Officer Conference Call Participants Steven Trainor Presentation Steven Trainor Good morning, everyone. I'm Steven Trainor, Vice President with Morgan Stanley.

Seeking Alpha • Sep 10, 2025